DNA fragmentation and apoptosis induced by safranal in human prostate cancer cell line

Indian Journal of Urology

Volumn 29, Issue 3, 2013, Pages 177-183

  Samarghandian, Saeed ^a   Shabestari, Mahmoud M ^b  

^a NEYSHABUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Apoptosis; cytotoxicity; DNA; PC 3; safranal

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; COLORING AGENT; LIPOCORTIN 5; PROPIDIUM IODIDE; SAFRANAL; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL DEATH; CELL GROWTH; CELL STRUCTURE; CELL VIABILITY; CONCENTRATION (PARAMETERS); DNA DETERMINATION; DNA FRAGMENTATION; DOSE RESPONSE; DRUG CYTOTOXICITY; FETUS; FLOW CYTOMETRY; GEL ELECTROPHORESIS; GROWTH INHIBITION; HISTOGRAM; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IC 50; LUNG FIBROBLAST; MALE; PROSTATE CANCER;

EID: 84884625812     PISSN: 09701591     EISSN: 19983824     Source Type: Journal    
DOI: 10.4103/0970-1591.117278     Document Type: Article

References (41)

1. Sharifi N, Gulley JL, Dahut WL. Androgen deprivation therapy for prostate cancer. JAMA 2005;294:238-44.
2. Crawford ED, Eisenberger MA, McLeod DG, Spaulding JT, Benson R, Dorr FA, et al. A controlled trial of leuprolide with and without flutamide in prostatic carcinoma. N Engl J Med 1989;321:419-24.
3. Eisenberger MA, Blumenstein BA, Crawford ED, Miller G, McLeod DG, Loehrer PJ, et al. Bilateral orchiectomy with or without flutamide for metastatic prostate cancer. N Engl J Med 1998;339:1036-42.
4. Tsao AS, Kim ES, Hong WK. Chemoprevention of cancer. CA Cancer J Clin 2004;54:150-80.
5. Samarghandian S, Afshari JT, Davoodi S. Chrysin reduces proliferation and induces apoptosis in the human prostate cancer cell line pc-3. Clinics (Sao Paulo) 2011;66:1073-9.
6. Winterhalter P, Staudinger M. Saffron-renewed interest in an ancient spice. Food Rev Int 2000;16:39-59.
7. Premkumar K, Abraham SK, Santhiya ST, Gopinath PM, Ramesh A. Inhibition of genotoxicity by saffron (Crocus sativus L.) in mice. Drug Chem Toxicol 2001;24:421-8.
8. Abdullaev FI. Cancer chemopreventive and tumoricidal properties of saffron (Crocus sativus L.). Exp Biol Med 2002;247:20-5.
9. Samarghandian S, Tavakkol Afshari J, Davoodi S. Suppression of pulmonary tumor promotion and induction of apoptosis by Crocus sativus L. extraction. Appl Biochem Biotechnol 2011;164:238-47.
10. Hosseinzadeh H, Khosravan V. Anticonvulsant effects of aqueous and ethanolic extracts of Crocus sativus L. stigmas in mice. Arch Iran Med 2002;5:44-7.
11. Hosseinzadeh H, Karimi GH, Niapoor M. Antidepressant effects of Crocus sativus stigma extracts and its constituents, crocin and safranal, in mice. Acta Hortic 2004;650:435-45.
12. Hosseinzadeh H, Younesi HM. Antinociceptive and anti-inflammatory effects of Crocus sativus L. stigma and petal extracts in mice. BMC Pharmacol 2002;2:7.
13. Zhang YX, Sugiura M, Saito H, Shoyama Y. Acute effects of Crocus sativus L. on passive avoidance performance in mice. Biol Pharm Bull 1994;17:217-21.
14. Premkumar K, Abraham SK, Santhiya ST, Ramesh A. Protective effects of saffron (Crocus sativus L.) on genotoxins-induced oxidative stress in swiss albino mice. Phytother Res 2003;17:614-7.
15. Bathaie SZ, Mousavi SZ. New applications and mechanisms of action of saffron and its important ingredients. Crit Rev Food Sci Nutr 2010;50:761-86. Review.
16. Tarantilis PA, Morjani H, Polissiou M, Manfait M. Inhibition of growth and induction of differentiation promyelocytic leukemia (HL-60) by carotenoids from Crocus sativus L. Anticancer Res1994;14:1913-8.
17. Escribano J, Alonso GL, Coca-Prados M, Fernández JA. Crocin, safranal and picocrocin from saffron (Crocus sativus L.) inhibit the growth of human cancer cells in vitro. Cancer Lett 1996;100:23-30.
18. Abdullaev FI. Inhibitory effect of crocetin on intracellular nucleic acid and protein synthesis in malignant cells. Toxicol Lett 1994;40:243-51.
19. Yawata A. Prolonged cell survival enhances peritoneal dissemination of gastric cancer cells. Oncogene 1998;16:2681-6.
20. Cragg GM, Newman DJ. Antineoplastic agents from natural sources: Achievements and future directions. Expert Opin Investig Drugs 2000;9:2783-97.
21. Cragg GM, Newman DJ. Plants as a source of anti-cancer agents. J Ethnopharmacol 2005;100:72-9.
22. Cragg GM, Schepartz SA, Suffness M, Grever MR. The taxol supply crisis. New NCI policies for handling the large-scale production of novel product anticancer and anti-HIV agents. J Nat Prod 1993;56:1657-68.
23. Abdullaev FI, Espinosa-Aguirre JJ. Biomedical properties of saffron and its potential use in cancer therapy and chemoprevention trials. Cancer Detect Prev 2004;28:426-32.
24. Kianbakht S. A systematic review on pharmacology of saffron and its active constituents. J Med Plants 2009;28:1-23.
25. Alonso GL, Salinas MR, Garijo J. Method to determine the authenticity of aroma of saffron (Crocus sativus L.). J Food Prot 1998;61:1525-8.
26. Nair SC, Pannikar B, Pannikar KR. Antitumour activity of saffron (Crocus sativus). Cancer Lett 1991;57:109-14.
27. Gutheil WG, Reed G, Ray A, Anant S, Dhar A. Crocetin: An agent derived from saffron for prevention and therapy for cancer. Curr Pharm Biotechnol 2012;13:173-9.
28. Morjani H, Tarantilis P, Polissiou M, Manfait M. Growth inhibition and induction of crythoid differentiation activity by crocin, dimethylcrocetin and '-carotene on K562 tumor cells. Anticancer Res 1990;10:1398-406.
29. Nair SC, Salomi MJ, Varghese CD, Pannikar B, Pannikar KR. Effect of saffron on thymocyte proliferation, intracellular gluthathione levels and its antitumor activity. Biofactors 1992;4:51-4.
30. Escribano J, Diaz-Guerra MJ, Riese HH, Alvarez A, Proenza R, Fernández JA. The cytotoxic effect of glucoconjugate extracted from corms of saffron plant (Crocus sativus) on human cell lines in culture. Planta Med 2000;66:157-62.
31. Escribano J, Piqueras A, Medina J, Rubio A, Alvarez-Orti M, Fernández JA. Production of a cytotoxic proteoglycan using callus culture of saffron corms (Crocus sativus L.). J Biotechnol 1999;73:53-9.
32. Garcia-Olmo DC, Riese HH, Escribano J, Ontañon J, Fernández JA, Atienzar M, et al. Effects of long-term treatment of colon adenocarcinoma with crocin, a carotenoid from saffron (Crocus sativus L.): An experimental study in the rats. Nutr Cancer 1999;35:120-6.
33. Molnar J, Szabo D, Pusztai R, Mucsi I, Berek L, Ocsovski I, et al. Membrane associated antitumor effects of crocine-, ginseniside-and cannabinoid derivates. Anticancer Res 2000;20:861-7.
34. Samarghandian S, Boskabady MH, Davoodi S. Use of in vitro assays to assess the potential antiproliferative and cytotoxic effects of saffron (Crocus sativus L.) in human lung cancer cell line. Pharmacogn Mag2010;6:309-14.
35. Assimopoulou AN, Sinakos Z, Papageorgiou VP. Radical scavenging activity of Crocus sativus L. extract and its bioactive constituents. Phytother Res 2005;19:997-1000.
36. Pintado C, Miguel A, Acevedo O, Nozal L, Novella JL, Rotger R. Bactericidal effect of saffron (Crocus sativus L.) on Salmonella enterica during storage. Food Control 2011;22:638-42.
37. Kanakis CD, Tarantilis PA, Tajmir-Riahi HA, Polissiou MG. DNA interaction with saffron's secondary metabolites safranal, crocetin, and dimethylcrocetin. DNA Cell Biol 2007;1:63-70.
38. Abdullaev FI. Biological effects of saffron. Biofactors 1993;4:83-6.
39. Guchelaar HJ, Uges DR, de Vries EG, Oosterhuis JW, Mulder NH. Combination therapy with cisplatin: Modulation of activity and tumour sensitivity. Clin Oncol 1992;4:388-93.
40. Mailloux A, Grenet K, Bruneel A, Bénéteau-Burnat B, Vaubourdolle M. Anticancer drugs induce necrosis of human endothelial cells involving both oncosis and apoptosis. Eur J Cell Biol 2001;80:442-9.
41. Kasibhatla S, Tseng B. Why target apoptosis in cancer treatment?. Mol Cancer Ther 2003;2:573-80.